Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Revvity

Revvity Announces Financial Results for the Third Quarter of 2024
From Revvity
Via Business Wire
Tickers RVTY
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
Tickers RVTY
Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories
From Revvity
Via Business Wire
Tickers RVTY
Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact Report
From Revvity
Via Business Wire
Tickers RVTY
Revvity To Hold Earnings Call on Monday, November 4, 2024
From Revvity
Via Business Wire
Tickers RVTY
Revvity's EUROIMMUN Launches Solution for Specific Typing of Alzheimer's Disease Associated APOE Gene
From Revvity
Via Business Wire
Tickers RVTY
Revvity to Present at Upcoming Investor Conferences
From Revvity
Via Business Wire
Tickers RVTY
Revvity Announces Financial Results for the Second Quarter of 2024
From Revvity
Via Business Wire
Tickers RVTY
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
Tickers RVTY
Revvity To Hold Earnings Call on Monday, July 29, 2024
From Revvity
Via Business Wire
Tickers RVTY
Revvity to Present at Goldman Sachs Global Healthcare Conference
From Revvity
Via Business Wire
Tickers RVTY
Revvity Announces Financial Results for the First Quarter of 2024
From Revvity
Via Business Wire
Tickers RVTY
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
Tickers RVTY
Revvity to Present at BofA Securities 2024 Health Care Conference
From Revvity
Via Business Wire
Tickers RVTY
Revvity Unveils a New Era of Automated Tuberculosis Testing
From Revvity
Via Business Wire
Tickers RVTY
Revvity To Hold Earnings Call on Monday, April 29, 2024
From Revvity
Via Business Wire
Tickers RVTY
Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners
From Revvity
Via Business Wire
Tickers RVTY
Preliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire Software
From Revvity
Via Business Wire
Tickers RVTY
Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group
From Revvity
Via Business Wire
Tickers RVTY
Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication
From Revvity
Via Business Wire
Tickers RVTY
Revvity Introduces New Workflow to Accelerate Newborn Sequencing Research
From Revvity
Via Business Wire
Revvity to Present at Upcoming Investor Conferences
From Revvity
Via Business Wire
Tickers RVTY
Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven Decisions
From Revvity
Via Business Wire
Tickers RVTY
Propelling Diagnostics and Life Sciences Innovation from Early Phase Research to the Clinic: Revvity Showcases Cutting-Edge Solutions at SLAS2024
From Revvity
Via Business Wire
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2023
From Revvity
Via Business Wire
Tickers RVTY
Revvity Elects Sophie Vandebroek and Michael Klobuchar to its Board of Directors
From Revvity
Via Business Wire
Tickers RVTY
Revvity Board Declares Quarterly Dividend
From Revvity
Via Business Wire
Tickers RVTY
Revvity to Hold Earnings Call on Thursday, February 1, 2024; Provides Update on Financial Performance
From Revvity
Via Business Wire
Tickers RVTY
Revvity to Present at J.P. Morgan Healthcare Conference
From Revvity
Via Business Wire
Tickers RVTY
Revvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCID
From Revvity
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.